1. Incentive to innovation through patent rights; 2. The patentability requirements and patent quality; 3. Pre-grant opposition; 4. Non-extension of the patent term; 5. Public non-commercial use; 6. Pipeline patents - or revalidation patents; 7. New forms of known substances and new uses; 8. The sanitary agency's (ANVISA) prior consent; 9. Undisclosed test data protection; 10. Sham litigation; 11. Compulsory licence; 12. Genetic resources, traditional knowledge, and benefit sharing; 13. Prize system as an alternative to promote innovation; 14. Software patents; 15. Patent prosecution highway (PPH); 16. Patent backlog and patent quality; 17. Creation of the council of intellectual property rights (CoDiPI), and the role of the inter-ministerial group on IP (GIPI); 18. The Brazilian patent office (INPI): headquarters in the federal district; 19. Executive summary.